Skip to content

Advertisement

Population Health Metrics

What do you think about BMC? Take part in

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Synergism of verbal autopsy and diagnostic pathology autopsy for improved accuracy of mortality data

Population Health Metrics20119:25

https://doi.org/10.1186/1478-7954-9-25

Received: 15 April 2011

Accepted: 1 August 2011

Published: 1 August 2011

Commentary

This series provides an important opportunity to consider how diagnostic pathology autopsy could be used in conjunction with verbal autopsy to provide more accurate cause of death and mortality data in all countries, and specifically in those countries with inadequate or nonexistent death registrations systems. For the purposes of this commentary, the term "autopsy" will denote the medical-pathology diagnostic procedure, in contrast to "verbal autopsy."

The term "autopsy" means "to see or observe for oneself," but traditional use has been reserved for the postmortem examination of a (dead) body by a physician/pathologist, in order to identify diseases and injuries and determine the cause(s) of death. This medical-diagnostic pathology procedure integrates trained observation of the external and internal body with dissection or other invasive procedures, in order to obtain tissue samples, which are evaluated by microscopy and other specialized laboratory modalities, including chemical, toxicologic, genetic, and molecular biologic analyses. Used more broadly, the term "autopsy" reflects the aggregate of procedures used for postmortem medical diagnosis or death investigation, including investigative procedures that identify information about the deceased's medical history and the circumstances and scene of his/her death.

To most pathologists and physicians, the term "verbal autopsy" seems a contradiction in terms. However, it is a clearly defined procedure, which allows classification of cause of death and cause-specific mortality by the analysis of data derived from structured interviews of family, friends, and caretakers, as well as review of any available medical records [1]. As more than two-thirds of the world's population lives and dies in countries that lack functional vital registration systems, and in which most deaths occur outside of medical facilities and are neither enumerated nor classified by cause, verbal autopsy has become the primary methodology for determining population-based cause-specific mortality [2, 3]. The development of computerized algorithmic systems for determination of cause of death by analysis of verbal autopsy data is a major focus of health metrics research, and emphasis is currently focused on using the recently-completed dataset from the Population Health Metrics Research Consortium (PHMRC) project that will allow analysis of verbal autopsy data collected from more than 12,000 hospitalized patients with causes of death established by rigorous clinical criteria.

The accuracy of verbal autopsy depends in large part on the quality of the diagnostic criteria, as well as on the age of the deceased and the type of diseases that are involved. Deaths associated with nonspecific signs and symptoms are especially problematic. The recent controversy about malaria mortality in India was a newsworthy example of the difficulty of differentiating malaria-caused deaths from those due to other febrile illnesses, such as septicemia, meningitis, encephalitis, and pneumonia [4]. Other areas of poor diagnostic specificity include maternal deaths, perinatal deaths, and stillbirths. Verbal autopsy has not been validated using deaths in which diagnostic pathology autopsies have been performed to determine the cause of death.

Diagnostic pathology autopsies have long been considered the "gold standard" for cause of death determination. Although autopsy rates are generally low in many developed countries, estimated at less than 5% in US hospital deaths, studies have continued to demonstrate substantial discordance between clinically- and autopsy-determined causes of death despite technologic advances in diagnostic modalities. These discrepancies are reflected in both clinical records and death certificates. Major diagnostic error rates involving the primary cause of death have ranged from 10% to more than 30%, even in a recent study that suggested a decline in the autopsy detection of unsuspected diagnoses [5]. The extent of antemortem diagnostic workup did not predict autopsy discrepancy rates. It is still widely accepted that a properly performed autopsy and death review or investigation can provide the most accurate determination of cause of death. The contributions of autopsy to a family's understanding of a death, to the clinician's understanding of a death, to discovery of new disease processes or effects of therapy, and to medical education are well established [68].

Autopsy-based studies of cause of death in Africa have also confirmed a high rate of diagnostic discrepancy. In a population-based autopsy study of HIV-1 infected gold miners, discrepancies between clinical and autopsy diagnoses were high, with 51% of infections and 55% of pulmonary tuberculosis diagnosed at autopsy having been missed clinically [9]. A study in Maputo, Mozambique noted that autopsies identified more specific diagnoses than death registries, resulting in a different distribution of leading causes of death [10]. A review of the autopsy series in sub-Saharan Africa from 1992 to 2010 showed only a weak correlation between clinical diagnosis and pathologic findings in HIV-positive individuals [11]. In a unique autopsy-based study of maternal deaths, a 40% discrepancy rate between clinical and autopsy diagnoses was identified in a tertiary referral hospital in Mozambique from 2002 to 2004 [12]. Given that verbal autopsy datasets frequently do not have any medical sources of information, it is even more likely that there are substantial discrepancies between diagnostic autopsy- and verbal autopsy-determined causes of death.

A major advantage of a diagnostic autopsy is that it can identify a cause or causes of death based on pathologic tissue diagnosis. Even in deaths in which pathologic examination does not identify a definite cause of death, that information can be integrated into the death investigation process to guide the performance of additional studies and the formulation of the most likely cause of death based on all available diagnostic information. Autopsy also identifies chronic and infectious disease processes that may not be the direct cause of death, permitting assessment of prevalence for these processes. Another advantage is that the creation of tissue repositories by preservation of tissue for histologic studies may facilitate later disease discovery and characterization, allowing modification of mortality data based on medical scientific advancement.

A major impediment to the performance of diagnostic pathology autopsies is the requirement for trained pathologists and assistants and histologic laboratory infrastructure for processing tissues for microscopy and preserving tissues, not currently available in many low- and middle-resource countries, particularly in nonurban settings. However, compared with many diagnostic modalities, such as those required for radiologic imaging, autopsy is a relatively low-tech and inexpensive procedure, which utilizes the same clinical and anatomic pathology laboratory resources needed for the provision of quality medical care in these settings. Another concern is the impact of cultural and religious attitudes about death and the handling of dead bodies. As this varies by country, culture and religion, this issue will need to be addressed on a case-by-case basis. Education, discussion, respectful communication and practice, and modification and limitation of invasive procedures for community acceptance could contribute to acceptance of this postmortem diagnostic procedure.

Verbal autopsy is a valuable indirect system for establishing cause of death and cause-specific mortality, but like any clinical and historical investigation, it will misclassify a substantial number of deaths when compared to the true "gold standard" for death classification, diagnostic pathology autopsy. Too many natural disease processes have similar presentations, symptoms, and signs, and the same assumptions that result in inaccurate cause of death determination in up to 40% of physician-certified deaths will be present in verbal autopsy data. What is now needed in low- and middle-resource countries are robust studies of the concordance of verbal and diagnostic pathology autopsy to assess the contribution that diagnostic pathology autopsy can make to the quality of verbal autopsy and other mortality data. Similar studies would also be valuable in developed countries with reportedly high-quality cause of death data. Continuous evaluation of a proportion of deaths by diagnostic pathology autopsy in conjunction with verbal autopsy could promote continuous quality assessment and improvement of mortality data, and at the same time facilitate the identification of new or emerging disease processes.

Declarations

Authors’ Affiliations

(1)
Departments of Pathology and Laboratory Medicine, University of Washington School of Medicine
(2)
National Institute for Occupational Health, National Health Laboratory Service and School of Public Health, Faculty of Health Sciences, University of the Witwatersrand
(3)
Massachusetts General Hospital (MGH)-Pathology

References

  1. World Health Organization:Verbal Autopsy Standards: Ascertaining and attributing causes of death. [http://www.who.int/whosis/mort/verbalautopsystandards/en/]
  2. Soleman N, Chandramohan D, Shibuya K: Verbal autopsy: Current practices and challenges. Bulletin of the World Health Organization 2006, 84: 239-245. 10.2471/BLT.05.027003View ArticlePubMedPubMed CentralGoogle Scholar
  3. Fottrell E, Byass P: Verbal autopsy: Methods in transition. Epidemiol Rev 2010, 32: 38-55. 10.1093/epirev/mxq003View ArticlePubMedGoogle Scholar
  4. Butler D: Verbal autopsy methods questioned: Controversy flares over malaria mortality levels in India. Nature 2010, 467: 1015. 10.1038/4671015aView ArticlePubMedGoogle Scholar
  5. Shojania KG, Burton EC, McDonald KM, Goldman L: Changes in rates of autopsy-detected diagnostic errors over time--A systematic review. JAMA 2003, 289: 2849-2856. 10.1001/jama.289.21.2849View ArticlePubMedGoogle Scholar
  6. Goldman L, Sayson R, Robbins ZAZ, Cohn LH, Bettman M, Weisberg M: The value of the autopsy in three medical eras. N Engl J Med 1983, 308: 1000-1005. 10.1056/NEJM198304283081704View ArticlePubMedGoogle Scholar
  7. Scordi-Bello IA, Kalb TH, Lento PA: Clinical setting and extent of premortem evaluation do not predict autopsy discrepancy rates. Modern Pathology 2010, 23: 1225-1230. 10.1038/modpathol.2010.107View ArticlePubMedGoogle Scholar
  8. Ayoub T, Chow J: The conventional autopsy in modern medicine. J R Soc Med 2008, 101: 177-181.PubMedPubMed CentralGoogle Scholar
  9. Murray J, Sonnenberg P, Nelson G, Bester A, Shearer S, Glynn JR: Cause of death and presence of respiratory disease at autopsy in an HIV-1 seroconversion cohort of southern African gold miners. AIDS 2007,21(supple 6):S97-104.View ArticlePubMedGoogle Scholar
  10. Dgedge M, Novoa A, Macassa G, Sacarlal J, Black J, Michaud C, Cliff J: The burden of disease in Maputo City, Mozambique: Registered and autopsied deaths in 1994. Bulletin of the World Health Organization 2001, 79: 546-552.PubMedPubMed CentralGoogle Scholar
  11. Cox JA, Lukande RL, Lucas S, Nelson AM, Van Marck E, Colebunders R: Autopsy causes of death in HIV positive individuals in sub-Saharan Africa and correlation with clinical diagnoses. AIDS Rev 2010, 12: 183-194.PubMedGoogle Scholar
  12. Ordi J, Ismail MR, Carrilho C, Romagosa C, Osman N, Machungo F, Bombí JA, Balasch J, Alonso PL, Menéndez C: Clinico-pathological discrepancies in the diagnosis of causes of maternal death in sub-Sahara Africa: retrospective analysis. PLOS Med 2009,6(2):e100036.View ArticleGoogle Scholar

Copyright

© Fligner et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement